EU Shifts To Centralized OTC Process At Member States’ Expense – GSK Exec
This article was originally published in The Tan Sheet
Executive Summary
Europe's development of a centralized process for approving nonprescription pharmaceuticals is sapping the resources of the regulatory agencies of European Union member states, a GlaxoSmithKline regulatory executive says